This new product keeps the sinuses open after sinus surgery delivering medication and support where it’s needed most.
Sinus surgery is often used to alleviate symptoms related to chronic sinusitis, one of the most common health conditions in the United States. For many patients, chronic sinusitis can be a debilitating condition that feels like a never-ending cold. Symptoms include congestion, decreased sense of smell, facial pain or pressure, and persistent post-nasal drip.
Broward Sinus Doctors are among the first in the United States to begin using the new product. The small device is a dissolvable medicated stent specifically designed to be placed after surgery in the frontal (behind the forehead) and maxillary (behind the cheeks) sinuses.
PROPEL Contour incorporates a unique hourglass design that conforms to the sinus openings, delivering medication and mechanical support where it is needed to optimize surgical outcomes. PROPEL Contour is clinically proven to reduce the need for post-operative interventions (a combination of surgical treatments and/or oral steroids) by 65%1.
The PROPEL family of dissolvable drug-eluting sinus stents, which now includes PROPEL Contour, may be used in patients undergoing ethmoid, frontal or maxillary surgeries. This represents the majority of procedures for the treatment of chronic sinusitis.
The PROPEL sinus implants are intended for use following sinus surgery to maintain the sinus openings and to locally deliver a drug to the sinuses: PROPEL for use in the ethmoid sinus, PROPEL Mini for use in the ethmoid sinus and frontal sinus opening and PROPEL Contour for use in the frontal and maxillary sinus openings. The products are intended for use in patients ≥18 years of age. These products are not intended for people who are allergic to the drug (mometasone furoate) or to certain polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, movement of the implant (within or out of the sinus), possible side effects of the drug, infection, and nose bleed. For more information on the risks and benefits of PROPEL sinus implants, please talk to your doctor. The FDA approved labeling can be found at www.IntersectENT.com. Rx only. INTERSECT ENT and PROPEL are registered trademarks of Intersect ENT, Inc. in the United States and other countries.
Our physicians are available for appointments to discuss chronic sinusitis, sinus surgery as a possible treatment option, as well as details about this new non-invasive product.